TREM2 mutations are risk factor for sporadic Alzheimer’s disease, and transgenic TREM2 deficiency in an AD murine model accelerates amyloid plaque deposition and neuron loss (Colonna and Wang, 2016; Herz et al., 2021). The gene discussed is TREM2; the disease is amyloidosis.